We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Guidance on Microdose Radiopharmaceutical Diagnostic Drugs
FDA Finalizes Guidance on Microdose Radiopharmaceutical Diagnostic Drugs
Sponsors conducting nonclinical radiopharmaceutical diagnostic drug trials can seek waivers for specific nonclinical pharmacology or toxicology studies, according to final guidance from the FDA.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor